{"id":154642,"date":"2026-07-15T11:28:32","date_gmt":"2026-07-15T11:28:32","guid":{"rendered":"https:\/\/pabau.com\/?p=154642"},"modified":"2026-08-17T12:09:27","modified_gmt":"2026-08-17T12:09:27","slug":"icd-10-code-c130","status":"publish","type":"post","link":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/","title":{"rendered":"ICD-10 Code C13.0: Malignant neoplasm of postcricoid region"},"content":{"rendered":"\n<script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"MedicalWebPage\",\"headline\":\"ICD-10 Code C13.0: Malignant neoplasm of postcricoid region\",\"description\":\"ICD-10 Code C13.0 covers malignant neoplasm of postcricoid region (hypopharynx). Billable for FY2026. Includes DRG grouping, coding guidelines, and related codes.\",\"url\":\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-c130\/\",\"audience\":{\"@type\":\"MedicalAudience\",\"audienceType\":\"Clinician\"},\"reviewedBy\":{\"@type\":\"Person\",\"name\":\"Dr Vanja Kitanova\",\"jobTitle\":\"Medical Reviewer\",\"affiliation\":{\"@type\":\"Organization\",\"name\":\"Pabau\"},\"knowsAbout\":[\"Medical Coding\",\"Clinical Documentation\",\"Healthcare Billing\",\"Clinical Safety\"],\"sameAs\":\"https:\/\/pabau.com\/blog\/author\/vanja\/\"},\"datePublished\":\"2026-07-15\",\"dateModified\":\"2026-07-15\"}<\/script>\n\n\n        <div id=\"key_takeaways\">\n            <div class=\"header\">\n                                    <img decoding=\"async\" src=\"https:\/\/pabau.com\/wp-content\/uploads\/2025\/12\/Key-Takeaways-Icon.svg\" alt=\"Key Takeaways\" height=\"42\" width=\"42\">\n                                <h3>Key Takeaways<\/h3>\n            <\/div>\n            <div class=\"list\">\n                                                            <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>ICD-10 Code C13.0 is the billable diagnosis code for malignant neoplasm of postcricoid region, a subsite of the hypopharynx<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>C13.0 is valid for FY2026 HIPAA-covered transactions and groups under MS-DRG v43.0<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Use C13.0 only when pathology reports specifically identify the postcricoid region; choose C13.9 for unspecified hypopharynx malignancies<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#3D3D46\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p>Pabau&#8217;s claims management software supports accurate ICD-10-CM code capture and claim submission workflows for oncology and specialist practices<\/p>\n                        <\/div>\n                                                <\/div>\n        <\/div>\n    \n\n\n<p class=\"wp-block-paragraph\">ICD-10 Code C13.0 is a billable, four-character ICD-10-CM diagnosis code for malignant neoplasm of postcricoid region, a subsite of the hypopharynx located posterior to the cricoid cartilage. It falls within the C00-C96 neoplasm chapter of the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Hypopharyngeal cancers account for roughly 3-5% of head and neck malignancies and carry some of the poorest five-year survival rates in that category, which makes accurate subsite coding important for both reimbursement and cancer registry data quality.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Practice management software like Pabau. This reduces downstream errors before a claim ever leaves the practice.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/diagnostic_codes\/icd-10-code-c130\/automate-claims-through-healthcode.webp\" alt=\"Automate claims and billing with Pabau\"\/><figcaption class=\"wp-element-caption\"><em>Automate claims and billing with Pabau<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\">\n<div class=\"wp-block-embed__wrapper\">\n<iframe title=\"ICD-10 Revisions: Stay Updated or Fall Behind\" width=\"800\" height=\"450\" src=\"https:\/\/www.youtube.com\/embed\/bqAyb-BCA0w?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div>\n<\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">This reference covers code validity, anatomical context, the full C13 subcode family, Applicable To and Excludes notes, MS-DRG grouping, and step-by-step coding guidance for FY2026.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Code details at a glance<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The table below summarizes the key administrative facts coders need before submitting any claim for malignant conditions.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Field<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Detail<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Code<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C13.0<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Full description<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of postcricoid region<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Code type<\/td>\n<td style=\"padding:12px 16px;color:#374151\">ICD-10-CM diagnosis code<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Billable status<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Billable \/ valid for HIPAA-covered transaction submission<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Fiscal year validity<\/td>\n<td style=\"padding:12px 16px;color:#374151\">FY2026 (October 1, 2025 to September 30, 2026)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Code block<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C00-C14 (Malignant neoplasms of lip, oral cavity and pharynx)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Parent category<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C13 (Malignant neoplasm of hypopharynx)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Chapter<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C00-D49 (Neoplasms)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">MS-DRG grouping<\/td>\n<td style=\"padding:12px 16px;color:#374151\">MS-DRG v43.0 (verify applicable DRG against CMS IPPS final rule)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<h2 class=\"wp-block-heading\">What is the postcricoid region?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The hypopharynx is the lowermost portion of the pharynx (throat), extending from the level of the hyoid bone down to the opening of the esophagus. It sits immediately behind the larynx and is divided into three anatomical subsites: the postcricoid region, the aryepiglottic folds\/arytenoids, and the posterior hypopharyngeal wall.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The postcricoid region occupies the area immediately posterior to the cricoid cartilage. It forms the anterior wall of the hypopharynx at its lower end and connects the hypopharynx to the cervical esophagus. Because it lies at this junction, tumors here frequently involve both the hypopharynx and the upper esophagus, which has direct implications for staging, surgical planning, and coding specificity.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Clinical significance for coders<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Squamous cell carcinoma (SCC) is the predominant histological type in this region, consistent with hypopharyngeal malignancies broadly. According to the <a href=\"https:\/\/icd.who.int\/browse10\/2019\/en\" target=\"_blank\" rel=\"nofollow noopener\">WHO ICD-10 reference<\/a>, postcricoid carcinoma is distinctly classified because its anatomical behavior, treatment approach, and prognosis differ from other hypopharyngeal subsites.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For coders, the postcricoid location matters because assigning C13.0 rather than the non-specific C13.9 reflects higher documentation quality and ensures the claim accurately represents the pathology documented in the operative or pathology report. The same specificity principle applies across other diagnostic categories.<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>Postcricoid region:<\/strong> posterior to cricoid cartilage; anterior wall of lower hypopharynx<\/li><li><strong>Typical presentation:<\/strong> dysphagia, voice changes, cervical lymphadenopathy<\/li><li><strong>Predominant histology:<\/strong> squamous cell carcinoma (SCC)<\/li><li><strong>Clinical overlap:<\/strong> tumors may extend to cervical esophagus, requiring additional codes<\/li><\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">C13.0 within the hypopharynx category<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">C13.0 is one of five billable subcodes within the C13 parent category. Selecting the right subcode depends entirely on the anatomical subsite documented by the treating clinician or pathologist. The <a href=\"https:\/\/www.aapc.com\/codes\/icd-10-codes-range\/\" target=\"_blank\" rel=\"nofollow noopener\">AAPC ICD-10-CM code lookup<\/a> and the official CMS tabular list both present these subcodes in the following hierarchy.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Description<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Billable<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Notes<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C13.0<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of postcricoid region<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Posterior to cricoid cartilage; lower hypopharynx<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C13.1<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of aryepiglottic fold, hypopharyngeal aspect<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Hypopharyngeal aspect only; laryngeal aspect uses C32.1<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C13.2<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of posterior wall of hypopharynx<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Posterior wall; distinct from postcricoid anterior wall<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C13.8<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of overlapping sites of hypopharynx<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Use when tumor crosses boundaries of two or more subsites<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C13.9<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of hypopharynx, unspecified<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Yes<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Use only when clinical documentation does not specify the subsite<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">A coder&#8217;s first question should always be: does the clinical documentation specify the anatomical subsite? If the operative note or pathology report identifies the postcricoid region, C13.0 is the correct code. If the physician documents only &#8222;hypopharynx cancer&#8220; without further subsite detail, C13.9 applies. This same specificity discipline reduces audit risk for codes like H65.31 and supports accurate MS-DRG assignment.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Applicable To notes and Excludes notes for C13.0<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Understanding the official notations in the ICD-10-CM tabular list is essential before assigning C13.0. These notes define what the code includes and what it explicitly does not cover.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Applicable To inclusions<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The Applicable To section at the C13 parent level identifies clinical terms that map to the hypopharynx category as a whole. For C13.0 specifically, the code applies when the documented malignancy arises in the postcricoid area, including the pharyngoesophageal junction area when the predominant site is the postcricoid region rather than the cervical esophagus.<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Malignant neoplasm of postcricoid area<\/li><li>Postcricoid carcinoma (when histologically confirmed as arising from the hypopharyngeal mucosa)<\/li><\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Excludes1 and Excludes2 notes<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The C13 parent category carries Excludes1 and Excludes2 notes that apply to all subcodes, including C13.0. Excludes1 means the excluded code can never be used at the same time as C13.0. Excludes2 means the excluded condition may coexist and both codes can be reported together when clinically documented.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Note type<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Excluded code<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">What it covers<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Coding implication<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Excludes2<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C12<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of pyriform sinus<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C13 parent-level note; may be coded alongside C13.0 if both sites are documented<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">Excludes2 (applies to C13.1, not C13.0)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C32.1<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of supraglottis \/ aryepiglottic fold, laryngeal aspect<\/td>\n<td style=\"padding:12px 16px;color:#374151\">This note sits under C13.1, not C13.0; laryngeal aryepiglottic fold is C32.1, hypopharyngeal aspect is C13.1<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">The aryepiglottic fold distinction is the most common source of error in this code family. The fold has two aspects: the hypopharyngeal aspect (C13.1) and the laryngeal aspect (C32.1). Always confirm which anatomical surface the pathologist describes before selecting between these two codes.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/diagnostic_codes\/icd-10-code-c130\/customizable-consent-and-intake-forms.webp\" alt=\"Customizable consent and intake forms\"\/><figcaption class=\"wp-element-caption\"><em>Customizable consent and intake forms<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n\n\n<h2 class=\"wp-block-heading\">MS-DRG grouping for hypopharynx cancer<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">When C13.0 is the principal diagnosis on an inpatient claim, it groups under the MS-DRG v43.0 system, typically within DRGs 011-013 (tracheostomy for face, mouth, and neck diagnoses, or laryngectomy, split by CC\/MCC status) or DRGs 146-148 (ear, nose, mouth, and throat malignancy, split by CC\/MCC status).<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">According to <a href=\"https:\/\/www.cms.gov\/medicare\/coding-billing\/icd-10-codes\" target=\"_blank\" rel=\"nofollow noopener\">CMS ICD-10 coding resources<\/a>, the specific DRG assignment depends on secondary diagnoses, procedures performed, and patient complications or comorbidities (CCs\/MCCs). Practices should verify the exact DRG assignment against the current CMS IPPS final rule tables for FY2026, because DRG weights and grouping logic are updated annually.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For head and neck malignancies involving the pharynx, MS-DRGs typically fall within the ear, nose, mouth, and throat chapter of the DRG classification. Treatment context matters, since a patient admitted for radiation treatment planning carries a different DRG than one admitted for surgical resection (pharyngolaryngectomy).<\/p>\n\n\n        <div id=\"pro_tip\">\n            <div class=\"img\">\n                <svg width=\"42\" height=\"42\" viewBox=\"0 0 42 42\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M12.6383 19.5238C12.6632 21.2071 12.8734 22.9926 12.0685 24.5523C11.0341 26.8917 8.45076 28.169 7.56292 30.5918C6.63082 33.1061 7.19505 36.185 9.31371 37.9786C10.929 39.5678 13.4183 39.9873 15.6061 39.5463C17.4592 39.073 19.1049 37.8388 19.9706 36.1608C20.781 34.7141 20.7866 32.9904 20.5293 31.3985C20.1006 29.3092 18.3775 27.8705 16.9807 26.362C14.8814 24.1005 14.6684 20.6854 15.595 17.8915C16.4331 15.4768 19.0026 14.2344 20.0425 11.9461C20.7202 10.6769 20.7506 9.20327 20.6068 7.81304C20.1864 5.40098 18.3139 3.23631 15.8716 2.56674C13.9742 2.03969 11.8224 2.30052 10.1739 3.37614C8.70522 4.34688 7.5878 5.86618 7.28356 7.58178C6.76081 9.82981 7.53525 12.2822 9.20307 13.9118C10.7658 15.4741 12.4806 17.2273 12.6383 19.5238Z\"\n                        fill=\"#2BADD4\" \/>\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M22.7048 19.8387C22.6822 22.3279 24.4507 24.6234 26.7493 25.4682C28.0531 25.961 29.4725 25.9183 30.7989 25.5487C32.0575 24.9955 33.301 24.2237 34.0069 23.0092C34.8384 21.5811 35.2982 19.8286 34.7832 18.2094C34.3611 16.2507 32.8739 14.6541 31.0275 13.9426C28.6736 12.9595 25.8073 13.7942 24.1719 15.7001C23.2022 16.8366 22.6143 18.3326 22.7048 19.8387Z\"\n                        fill=\"#2BADD4\" \/>\n                <\/svg>\n            <\/div>\n            <div class=\"text\">\n                <h3>Pro Tip<\/h3>\n                <p>Verify MS-DRG assignments for C13.0 claims directly against the CMS IPPS Final Rule Addenda files each October. DRG weights and logic change annually, and a stale reference can result in systematic undercoding or overbilling audit exposure across your oncology claims.<\/p>\n            <\/div>\n        <\/div>\n    \n\n\n<h2 class=\"wp-block-heading\">Coding guidelines and documentation requirements for ICD-10 Code C13.0<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The ICD-10-CM Official Guidelines for Coding and Reporting (Section I, C, Chapter 2) govern how neoplasm codes are selected and sequenced. For C13.0 specifically, coders and clinicians should apply the following step-by-step process.<\/p>\n\n\n\n<ol class=\"wp-block-list\"><li><strong>Confirm anatomical subsite in documentation.<\/strong> The pathology report, operative note, or multidisciplinary team (MDT) summary must explicitly state &#8222;postcricoid region.&#8220; If the documentation says &#8222;hypopharynx&#8220; without further specification, C13.9 applies.<\/li><li><strong>Use the Neoplasm Table in the ICD-10-CM Alphabetic Index.<\/strong> Navigate to &#8222;Neoplasm, neoplastic &#8211; hypopharynx, hypopharyngeal NEC &#8211; postcricoid region&#8220; to locate C13.0. This prevents direct code-book look-up errors. The <a href=\"https:\/\/icd10cmtool.cdc.gov\/\" target=\"_blank\" rel=\"nofollow noopener\">CDC\/NCHS ICD-10-CM web tool<\/a> provides a free, authoritative index search updated for FY2026.<\/li><li><strong>Determine first-listed vs. additional code sequencing.<\/strong> For inpatient claims, sequence C13.0 as the principal diagnosis when the malignancy is the condition chiefly responsible for the admission. For outpatient encounters (chemotherapy, radiation, or surveillance), sequence the appropriate reason for the encounter first (e.g., Z51.11 for chemotherapy) and report C13.0 as an additional code per ICD-10-CM Section I.C.2 guidelines.<\/li><li><strong>Report morphology and laterality where applicable.<\/strong> C13.0 does not have laterality options (the postcricoid region is a midline structure), so no laterality modifier is needed. Histological type (SCC versus adenocarcinoma) is not captured within C13.0 itself; a separate morphology code from the ICD-O-3 system may apply in cancer registry contexts.<\/li><li><strong>Check for overlapping lesion criteria.<\/strong> If the pathology report documents that the tumor crosses from the postcricoid region into an adjacent subsite (such as the posterior hypopharyngeal wall), use C13.8 (overlapping sites) rather than C13.0.<\/li><\/ol>\n\n\n\n<p class=\"wp-block-paragraph\">Thorough physician documentation drives every step of this process. Practices that use Pabau Scribe, our AI scribe, can capture structured notes that include anatomical subsite detail, reducing the need for query-back loops between coders and clinicians.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/diagnostic_codes\/icd-10-code-c130\/creating-treatment-notes-with-echo-ai.webp\" alt=\"Creating treatment notes with Pabau Scribe, our AI scribe\"\/><figcaption class=\"wp-element-caption\"><em>Creating treatment notes with Pabau Scribe, our AI scribe<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n\n\n<h2 class=\"wp-block-heading\">How C13.0 fits into the broader head and neck cancer ICD-10 code landscape<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Head and neck cancer coding spans the C00-C14 block of ICD-10-CM. Understanding where C13.0 sits within this broader structure helps coders navigate between adjacent codes and avoid misassignment, particularly for tumors near anatomical boundaries.<\/p>\n\n\n\n<table style=\"width:100%;border-collapse:separate;border-spacing:0;border-radius:12px;overflow:hidden;font-size:15px;line-height:1.5;margin:1.5em 0 2em;box-shadow:0 2px 12px rgba(0,0,0,0.08)\">\n<thead>\n<tr>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Code range<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Anatomical site<\/th>\n<th style=\"background:#121D36;color:#fff;padding:14px 16px;text-align:left;font-weight:600;font-size:14px;letter-spacing:0.3px;border-bottom:2px solid #2BADD4\">Relevance to C13.0<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C10<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of oropharynx<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Superior to hypopharynx; tumors can extend downward into C13 territory<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C13<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of hypopharynx (C13.0-C13.9)<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Parent category; C13.0 is the postcricoid subsite<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C14.0<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of pharynx, unspecified<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Non-specific pharynx code; avoid when subsite is documented<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0;background:#F9FAFB\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C15<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of esophagus<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Postcricoid tumors extending into cervical esophagus may require C15.3 in addition to or instead of C13.0<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #E8ECF0\">\n<td style=\"padding:12px 16px;font-weight:600;color:#121D36\">C32<\/td>\n<td style=\"padding:12px 16px;color:#374151\">Malignant neoplasm of larynx<\/td>\n<td style=\"padding:12px 16px;color:#374151\">C32.1 covers aryepiglottic fold, laryngeal aspect; not the same as C13.1<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n<p class=\"wp-block-paragraph\">The postcricoid region&#8217;s proximity to the esophagus creates a recurring coding challenge. When the surgical or endoscopic report documents that the primary tumor originates in the postcricoid region but also involves the cervical esophagus, clinical judgment and documentation quality determine whether C13.0 or C15.3 (malignant neoplasm of cervical esophagus) becomes the principal code.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">If both sites are equally involved and the origin is ambiguous, C13.8 (overlapping sites) may be the most defensible choice pending a physician query.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Oncology and ENT practices managing these complex cases benefit from <a href=\"https:\/\/pabau.com\/features\/medical-records-management\/\">structured patient records<\/a> that link pathology reports, operative summaries, and staging information directly to the encounter record. This integrated documentation approach supports both accurate patient care management and cleaner claim submission.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" src=\"https:\/\/cdn.pabau.com\/cdn\/attachments\/pulse\/content-engine\/diagnostic_codes\/icd-10-code-c130\/comprehensive-emr-patient-record-management.webp\" alt=\"Comprehensive EMR &#038; patient record management\"\/><figcaption class=\"wp-element-caption\"><em>Comprehensive EMR &#038; patient record management<\/em><\/figcaption><\/figure>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n\n        <div id=\"pro_tip\">\n            <div class=\"img\">\n                <svg width=\"42\" height=\"42\" viewBox=\"0 0 42 42\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M12.6383 19.5238C12.6632 21.2071 12.8734 22.9926 12.0685 24.5523C11.0341 26.8917 8.45076 28.169 7.56292 30.5918C6.63082 33.1061 7.19505 36.185 9.31371 37.9786C10.929 39.5678 13.4183 39.9873 15.6061 39.5463C17.4592 39.073 19.1049 37.8388 19.9706 36.1608C20.781 34.7141 20.7866 32.9904 20.5293 31.3985C20.1006 29.3092 18.3775 27.8705 16.9807 26.362C14.8814 24.1005 14.6684 20.6854 15.595 17.8915C16.4331 15.4768 19.0026 14.2344 20.0425 11.9461C20.7202 10.6769 20.7506 9.20327 20.6068 7.81304C20.1864 5.40098 18.3139 3.23631 15.8716 2.56674C13.9742 2.03969 11.8224 2.30052 10.1739 3.37614C8.70522 4.34688 7.5878 5.86618 7.28356 7.58178C6.76081 9.82981 7.53525 12.2822 9.20307 13.9118C10.7658 15.4741 12.4806 17.2273 12.6383 19.5238Z\"\n                        fill=\"#2BADD4\" \/>\n                    <path fill-rule=\"evenodd\" clip-rule=\"evenodd\"\n                        d=\"M22.7048 19.8387C22.6822 22.3279 24.4507 24.6234 26.7493 25.4682C28.0531 25.961 29.4725 25.9183 30.7989 25.5487C32.0575 24.9955 33.301 24.2237 34.0069 23.0092C34.8384 21.5811 35.2982 19.8286 34.7832 18.2094C34.3611 16.2507 32.8739 14.6541 31.0275 13.9426C28.6736 12.9595 25.8073 13.7942 24.1719 15.7001C23.2022 16.8366 22.6143 18.3326 22.7048 19.8387Z\"\n                        fill=\"#2BADD4\" \/>\n                <\/svg>\n            <\/div>\n            <div class=\"text\">\n                <h3>Pro Tip<\/h3>\n                <p>When a postcricoid tumor extends into the cervical esophagus, submit a physician query before coding. Document whether the primary site is the hypopharynx or the esophagus, because the answer determines not only the ICD-10-CM code but also the staging workup, surgical approach, and DRG grouping.<\/p>\n            <\/div>\n        <\/div>\n    \n\n\n<h2 class=\"wp-block-heading\">Related ICD-10 codes<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-c61\/\">ICD-10 code for prostate cancer \u2014 C61<\/a><\/li>\n\n\n<li><a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-c158\/\">ICD-10 code C15.8 \u2014 Esophageal cancer, overlapping sites<\/a><\/li>\n\n\n<li><a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-c179\/\">ICD-10 code C17.9 \u2014 Malignant neoplasm of small intestine, unspecified<\/a><\/li>\n\n\n<li><a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-c181\/\">ICD-10 code C18.1 \u2014 Malignant neoplasm of appendix<\/a><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Coding context and Pabau&#8217;s documentation workflow<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Accurate oncology coding requires more than knowing the correct code. It requires a documentation workflow that captures subsite-specific detail from the first clinical encounter through final billing. Missed or vague documentation is the leading cause of code uncertainty in head and neck malignancy cases.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pabau supports oncology and ENT practices with compliance management workflows that flag incomplete documentation fields before claims are submitted. Structured note templates built around ICD-10-CM specificity requirements help clinicians capture anatomical subsite at the point of care, which directly feeds into clean claim preparation.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For practices managing high volumes of complex oncology claims.<\/p>\n\n\n        <div id=\"book_a_demo\">\n            <div class=\"left-side\">\n                <div class=\"logo\">\n                    <img decoding=\"async\"\n                        src=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/01\/Logo.svg\"\n                        alt=\"Logo\"\n                        loading=\"lazy\"\n                    \/>\n                <\/div>\n\n                <h3 class=\"heading\">\n                    Reduce coding errors before they reach the payer                <\/h3>\n\n                <p class=\"description\">\n                    Pabau helps oncology and ENT practices capture accurate ICD-10-CM codes at the point of clinical documentation, reducing claim rework and supporting compliant submission workflows.                <\/p>\n\n                <div class=\"button-group\">\n                    <a href=\"\/book-demo\/\" class=\"btn btn-scale-effect btn-cta-color btn-md\">\n                        <span class=\"btn-text\">Book a demo<\/span>\n                        <div class=\"btn-icon btn-icon-right\" aria-hidden=\"true\">\n                            <svg\n                                width=\"14\"\n                                height=\"12\"\n                                viewBox=\"0 0 14 12\"\n                                fill=\"none\"\n                                xmlns=\"http:\/\/www.w3.org\/2000\/svg\"\n                            >\n                                <path\n                                    d=\"M0.75 4.77295C0.335786 4.77295 0 5.10874 0 5.52295C0 5.93716 0.335786 6.27295 0.75 6.27295V5.52295V4.77295ZM13.2803 6.05328C13.5732 5.76039 13.5732 5.28551 13.2803 4.99262L8.50736 0.219648C8.21447 -0.073245 7.73959 -0.073245 7.4467 0.219648C7.15381 0.512542 7.15381 0.987415 7.4467 1.28031L11.6893 5.52295L7.4467 9.76559C7.15381 10.0585 7.15381 10.5334 7.4467 10.8263C7.73959 11.1191 8.21447 11.1191 8.50736 10.8263L13.2803 6.05328ZM0.75 5.52295V6.27295L12.75 6.27295V5.52295V4.77295L0.75 4.77295V5.52295Z\"\n                                    fill=\"currentColor\"\n                                ><\/path>\n                            <\/svg>\n                        <\/div>\n                    <\/a>\n                <\/div>\n            <\/div>\n\n            <div class=\"right-side\">\n                <img decoding=\"async\"\n                    src=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/01\/Home-Page-Concept-4.webp\"\n                    alt=\"Pabau practice management dashboard for clinical documentation and claims\"\n                    loading=\"lazy\"\n                \/>\n            <\/div>\n        <\/div>\n        \n\n\n<h2 class=\"wp-block-heading\">Conclusion<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Hypopharyngeal malignancies are low-volume but high-complexity from a coding standpoint. ICD-10 Code C13.0 is the correct, billable code for malignant neoplasm of the postcricoid region, valid for FY2026, and distinct from the other four C13 subcodes by virtue of a single documented anatomical detail: that the primary tumor arises posterior to the cricoid cartilage.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The most common errors with this code fall into three categories:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Using C13.9 when documentation supports C13.0<\/li><li>Confusing the hypopharyngeal and laryngeal aspects of the aryepiglottic fold<\/li><li>Failing to apply C13.8 when a tumor genuinely crosses subsite boundaries<\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Structured documentation workflows, physician queries, and annual DRG verification eliminate the majority of these issues. Head and neck resections like pharyngolaryngectomy often involve surgical teams already using plastic surgery EMR software, which keeps ICD-10-CM documentation consistent across the surgical and oncology teams handling the same case.<\/p>\n\n\n        <div id=\"expert_picks\">\n            <div class=\"header\">\n                                    <img decoding=\"async\" src=\"https:\/\/pabau.com\/wp-content\/uploads\/2025\/11\/Expert-Picks.svg\" alt=\"Continue your research\" height=\"42\" width=\"42\">\n                                <h3>Continue your research<\/h3>\n            <\/div>\n            <div class=\"content\">\n                                                            <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Coding a related head and neck pathology?<\/strong> <a href=\"https:\/\/pabau.com\/diagnostic-codes\/icd-10-code-m312\/\">M31.2<\/a> covers lethal midline granuloma, a rare condition with its own subsite-specificity challenges.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Need a procedure code for supportive oncology care?<\/strong> <a href=\"https:\/\/pabau.com\/procedure-codes\/hcpcs-code-j0702\/\">J0702<\/a> covers betamethasone injections, commonly billed alongside cancer treatment plans.<\/p>\n                        <\/div>\n                                                                                <div class=\"item\">\n                            <div>\n                                <svg width=\"20\" height=\"27\" viewBox=\"0 0 20 27\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                                    <path\n                                        d=\"M18.6223 14.3857C19.1246 13.8975 19.1246 13.1045 18.6223 12.6162L12.1938 6.36621C11.6915 5.87793 10.8759 5.87793 10.3737 6.36621C9.87143 6.85449 9.87143 7.64746 10.3737 8.13574L14.6125 12.2529H2.28571C1.57455 12.2529 1 12.8115 1 13.5029C1 14.1943 1.57455 14.7529 2.28571 14.7529H14.6085L10.3777 18.8701C9.87545 19.3584 9.87545 20.1514 10.3777 20.6396C10.8799 21.1279 11.6955 21.1279 12.1978 20.6396L18.6263 14.3896L18.6223 14.3857Z\"\n                                        fill=\"#54B2D3\" \/>\n                                <\/svg>\n                            <\/div>\n                            <p><strong>Want a ready-made intake template?<\/strong> Pabau&#8217;s <a href=\"https:\/\/pabau.com\/templates\/audit-c-questionnaire\/\">AUDIT-C questionnaire template<\/a> gives practices a structured screening tool to pair with clinical documentation.<\/p>\n                        <\/div>\n                                                <\/div>\n        <\/div>\n    \n\n\n<h2 class=\"wp-block-heading\">Frequently Asked Questions<\/h2>\n\n\n\n<div class=\"schema-faq wp-block-yoast-faq-block\"><div class=\"schema-faq-section\" id=\"faq-question-1\"><h3 class=\"schema-faq-question\">What is ICD-10 Code C13.0?<\/h3> <p class=\"schema-faq-answer\">ICD-10 Code C13.0 is the billable ICD-10-CM diagnosis code for malignant neoplasm of postcricoid region, a subsite of the hypopharynx located posterior to the cricoid cartilage. It is valid for FY2026 HIPAA-covered transaction submission and falls within the C00-C14 block of the ICD-10-CM neoplasm chapter.<\/p><\/div><div class=\"schema-faq-section\" id=\"faq-question-2\"><h3 class=\"schema-faq-question\">Is C13.0 a billable ICD-10-CM code?<\/h3> <p class=\"schema-faq-answer\">Yes. C13.0 is a fully billable, four-character ICD-10-CM diagnosis code valid for submission on HIPAA-covered transactions for fiscal year 2026 (October 1, 2025 through September 30, 2026). It is confirmed as billable across CMS, CDC\/NCHS, and AAPC authoritative sources.<\/p><\/div><div class=\"schema-faq-section\" id=\"faq-question-3\"><h3 class=\"schema-faq-question\">What is the difference between C13.0 and C13.9?<\/h3> <p class=\"schema-faq-answer\">C13.0 specifies malignancy in the postcricoid region of the hypopharynx, while C13.9 indicates an unspecified hypopharynx malignancy. Use C13.0 when the pathology report or operative note explicitly identifies the postcricoid subsite. Use C13.9 only when clinical documentation does not specify the anatomical location within the hypopharynx.<\/p><\/div><div class=\"schema-faq-section\" id=\"faq-question-4\"><h3 class=\"schema-faq-question\">What DRG is associated with C13.0?<\/h3> <p class=\"schema-faq-answer\">C13.0 groups under the MS-DRG v43.0 system when it is the principal diagnosis on an inpatient claim. The specific DRG depends on secondary diagnoses, the presence of CCs or MCCs, and procedures performed. Verify the exact DRG assignment against the current CMS IPPS Final Rule tables annually, as grouping logic changes each fiscal year.<\/p><\/div><div class=\"schema-faq-section\" id=\"faq-question-5\"><h3 class=\"schema-faq-question\">What is the ICD-10 code for throat cancer?<\/h3> <p class=\"schema-faq-answer\">There is no single ICD-10-CM code for &#8222;throat cancer&#8220; because the throat encompasses multiple anatomical structures, each with its own code. Common options include C13.0-C13.9 for hypopharynx, C10.x for oropharynx, C14.0 for pharynx unspecified, and C32.x for larynx. The correct code depends on the specific anatomical subsite documented by the treating clinician or confirmed by pathology.<\/p><\/div><div class=\"schema-faq-section\" id=\"faq-question-6\"><h3 class=\"schema-faq-question\">Which ICD-10 codes are related to hypopharynx cancer?<\/h3> <p class=\"schema-faq-answer\">The C13 category covers all hypopharynx malignancies: C13.0 (postcricoid region), C13.1 (aryepiglottic fold, hypopharyngeal aspect), C13.2 (posterior wall), C13.8 (overlapping sites), and C13.9 (unspecified). Adjacent codes include C10.x for oropharynx, C14.0 for pharynx unspecified, C15.3 for cervical esophagus, and C32.1 for the laryngeal aspect of the aryepiglottic fold.<\/p><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ICD-10 Code C13.0 is a billable, four-character ICD-10-CM diagnosis code for malignant neoplasm of postcricoid region, a subsite of the hypopharynx located posterior to the cricoid cartilage. It falls within the C00-C96 neoplasm chapter of the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). Hypopharyngeal cancers account for roughly 3-5% of head and neck [&hellip;]<\/p>\n","protected":false},"author":77,"featured_media":154641,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_yoast_wpseo_linkdex":"88","_yoast_wpseo_content_score":"60","_yoast_wpseo_is_cornerstone":"","_yoast_wpseo_keywordsynonyms":"[\"\",\"\",\"\",\"\",\"\",\"\"]","_yoast_wpseo_focuskw_text_input":"","_seo_original_html":"","footnotes":""},"categories":[1549,1550],"tags":[4239,4240,1386,1305],"class_list":["post-154642","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-diagnostic-codes","category-icd-10-cm","tag-c13-0-diagnosis-code","tag-hypopharynx-cancer","tag-icd","tag-icd-10-codes"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>ICD-10 Code C13.0: Malignant neoplasm of postcricoid region<\/title>\n<meta name=\"description\" content=\"ICD-10 Code C13.0 covers malignant neoplasm of postcricoid region (hypopharynx). Billable for FY2026, with DRG grouping and coding guidance.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ICD-10 Code C13.0: Malignant neoplasm of postcricoid region\" \/>\n<meta property=\"og:description\" content=\"ICD-10 Code C13.0 covers malignant neoplasm of postcricoid region (hypopharynx). Billable for FY2026, with DRG grouping and coding guidance.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/\" \/>\n<meta property=\"og:site_name\" content=\"Pabau\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Pabau\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-15T11:28:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-17T12:09:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-c130.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Katy Piper\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@pabaucrm\" \/>\n<meta name=\"twitter:site\" content=\"@pabaucrm\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Katy Piper\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"12\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/\"},\"author\":{\"name\":\"Katy Piper\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#\\\/schema\\\/person\\\/5de22f4ff3ec59b1925ef02dce956d7d\"},\"headline\":\"ICD-10 Code C13.0: Malignant neoplasm of postcricoid region\",\"datePublished\":\"2026-07-15T11:28:32+00:00\",\"dateModified\":\"2026-08-17T12:09:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/\"},\"wordCount\":2272,\"publisher\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/icd-10-code-c130.webp\",\"keywords\":[\"C13.0 diagnosis code\",\"Hypopharynx cancer\",\"icd\",\"ICD-10 codes\"],\"articleSection\":[\"Diagnostic Codes\",\"ICD-10-CM\"],\"inLanguage\":\"de\"},{\"@type\":[\"WebPage\",\"FAQPage\"],\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/\",\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/\",\"name\":\"ICD-10 Code C13.0: Malignant neoplasm of postcricoid region\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/icd-10-code-c130.webp\",\"datePublished\":\"2026-07-15T11:28:32+00:00\",\"dateModified\":\"2026-08-17T12:09:27+00:00\",\"description\":\"ICD-10 Code C13.0 covers malignant neoplasm of postcricoid region (hypopharynx). Billable for FY2026, with DRG grouping and coding guidance.\",\"mainEntity\":[{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#faq-question-1\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#faq-question-2\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#faq-question-3\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#faq-question-4\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#faq-question-5\"},{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#faq-question-6\"}],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#primaryimage\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/icd-10-code-c130.webp\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/icd-10-code-c130.webp\",\"width\":1200,\"height\":630},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/\",\"name\":\"Pabau\",\"description\":\"Clinic Software for your Business | Go Paperless Today\",\"publisher\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pabau.com\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#organization\",\"name\":\"Pabau\",\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Logo-4-e1654525062364.png\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2022\\\/05\\\/Logo-4-e1654525062364.png\",\"width\":736,\"height\":195,\"caption\":\"Pabau\"},\"image\":{\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Pabau\\\/\",\"https:\\\/\\\/x.com\\\/pabaucrm\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/pabau-ltd\\\/\",\"https:\\\/\\\/www.instagram.com\\\/pabausoftware\\\/\"],\"description\":\"Pabau is an all-in-one healthcare practice management software platform designed for clinics, medspas, therapists, and medical professionals. It combines scheduling, electronic health records, clinical forms, payments, marketing automation, reporting, and patient engagement tools into one secure cloud system to help practices streamline operations and grow their business.\",\"foundingDate\":\"2011-10-20\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"201\",\"maxValue\":\"500\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/#\\\/schema\\\/person\\\/5de22f4ff3ec59b1925ef02dce956d7d\",\"name\":\"Katy Piper\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-Snip20260306_177-96x96.png\",\"url\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-Snip20260306_177-96x96.png\",\"contentUrl\":\"https:\\\/\\\/pabau.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-Snip20260306_177-96x96.png\",\"caption\":\"Katy Piper\"},\"description\":\"Katy Piper is a content writer covering aesthetics, dermatology, and clinic operations, with a knack for making clinical detail feel approachable. Outside of work, she's usually chasing her border collie around muddy fields or hunting down the best flat white in town.\",\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/blog\\\/author\\\/katy-piper\\\/\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#faq-question-1\",\"position\":1,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#faq-question-1\",\"name\":\"What is ICD-10 Code C13.0?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"ICD-10 Code C13.0 is the billable ICD-10-CM diagnosis code for malignant neoplasm of postcricoid region, a subsite of the hypopharynx located posterior to the cricoid cartilage. It is valid for FY2026 HIPAA-covered transaction submission and falls within the C00-C14 block of the ICD-10-CM neoplasm chapter.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#faq-question-2\",\"position\":2,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#faq-question-2\",\"name\":\"Is C13.0 a billable ICD-10-CM code?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes. C13.0 is a fully billable, four-character ICD-10-CM diagnosis code valid for submission on HIPAA-covered transactions for fiscal year 2026 (October 1, 2025 through September 30, 2026). It is confirmed as billable across CMS, CDC\\\/NCHS, and AAPC authoritative sources.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#faq-question-3\",\"position\":3,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#faq-question-3\",\"name\":\"What is the difference between C13.0 and C13.9?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"C13.0 specifies malignancy in the postcricoid region of the hypopharynx, while C13.9 indicates an unspecified hypopharynx malignancy. Use C13.0 when the pathology report or operative note explicitly identifies the postcricoid subsite. Use C13.9 only when clinical documentation does not specify the anatomical location within the hypopharynx.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#faq-question-4\",\"position\":4,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#faq-question-4\",\"name\":\"What DRG is associated with C13.0?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"C13.0 groups under the MS-DRG v43.0 system when it is the principal diagnosis on an inpatient claim. The specific DRG depends on secondary diagnoses, the presence of CCs or MCCs, and procedures performed. Verify the exact DRG assignment against the current CMS IPPS Final Rule tables annually, as grouping logic changes each fiscal year.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#faq-question-5\",\"position\":5,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#faq-question-5\",\"name\":\"What is the ICD-10 code for throat cancer?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"There is no single ICD-10-CM code for \\\"throat cancer\\\" because the throat encompasses multiple anatomical structures, each with its own code. Common options include C13.0-C13.9 for hypopharynx, C10.x for oropharynx, C14.0 for pharynx unspecified, and C32.x for larynx. The correct code depends on the specific anatomical subsite documented by the treating clinician or confirmed by pathology.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"},{\"@type\":\"Question\",\"@id\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#faq-question-6\",\"position\":6,\"url\":\"https:\\\/\\\/pabau.com\\\/de\\\/diagnostic-codes\\\/icd-10-code-c130\\\/#faq-question-6\",\"name\":\"Which ICD-10 codes are related to hypopharynx cancer?\",\"answerCount\":1,\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The C13 category covers all hypopharynx malignancies: C13.0 (postcricoid region), C13.1 (aryepiglottic fold, hypopharyngeal aspect), C13.2 (posterior wall), C13.8 (overlapping sites), and C13.9 (unspecified). Adjacent codes include C10.x for oropharynx, C14.0 for pharynx unspecified, C15.3 for cervical esophagus, and C32.1 for the laryngeal aspect of the aryepiglottic fold.\",\"inLanguage\":\"de\"},\"inLanguage\":\"de\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ICD-10 Code C13.0: Malignant neoplasm of postcricoid region","description":"ICD-10 Code C13.0 covers malignant neoplasm of postcricoid region (hypopharynx). Billable for FY2026, with DRG grouping and coding guidance.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/","og_locale":"de_DE","og_type":"article","og_title":"ICD-10 Code C13.0: Malignant neoplasm of postcricoid region","og_description":"ICD-10 Code C13.0 covers malignant neoplasm of postcricoid region (hypopharynx). Billable for FY2026, with DRG grouping and coding guidance.","og_url":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/","og_site_name":"Pabau","article_publisher":"https:\/\/www.facebook.com\/Pabau\/","article_published_time":"2026-07-15T11:28:32+00:00","article_modified_time":"2026-08-17T12:09:27+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-c130.webp","type":"image\/webp"}],"author":"Katy Piper","twitter_card":"summary_large_image","twitter_creator":"@pabaucrm","twitter_site":"@pabaucrm","twitter_misc":{"Verfasst von":"Katy Piper","Gesch\u00e4tzte Lesezeit":"12\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#article","isPartOf":{"@id":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/"},"author":{"name":"Katy Piper","@id":"https:\/\/pabau.com\/de\/#\/schema\/person\/5de22f4ff3ec59b1925ef02dce956d7d"},"headline":"ICD-10 Code C13.0: Malignant neoplasm of postcricoid region","datePublished":"2026-07-15T11:28:32+00:00","dateModified":"2026-08-17T12:09:27+00:00","mainEntityOfPage":{"@id":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/"},"wordCount":2272,"publisher":{"@id":"https:\/\/pabau.com\/de\/#organization"},"image":{"@id":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#primaryimage"},"thumbnailUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-c130.webp","keywords":["C13.0 diagnosis code","Hypopharynx cancer","icd","ICD-10 codes"],"articleSection":["Diagnostic Codes","ICD-10-CM"],"inLanguage":"de"},{"@type":["WebPage","FAQPage"],"@id":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/","url":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/","name":"ICD-10 Code C13.0: Malignant neoplasm of postcricoid region","isPartOf":{"@id":"https:\/\/pabau.com\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#primaryimage"},"image":{"@id":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#primaryimage"},"thumbnailUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-c130.webp","datePublished":"2026-07-15T11:28:32+00:00","dateModified":"2026-08-17T12:09:27+00:00","description":"ICD-10 Code C13.0 covers malignant neoplasm of postcricoid region (hypopharynx). Billable for FY2026, with DRG grouping and coding guidance.","mainEntity":[{"@id":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#faq-question-1"},{"@id":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#faq-question-2"},{"@id":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#faq-question-3"},{"@id":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#faq-question-4"},{"@id":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#faq-question-5"},{"@id":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#faq-question-6"}],"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#primaryimage","url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-c130.webp","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/07\/icd-10-code-c130.webp","width":1200,"height":630},{"@type":"WebSite","@id":"https:\/\/pabau.com\/de\/#website","url":"https:\/\/pabau.com\/de\/","name":"Pabau","description":"Clinic Software for your Business | Go Paperless Today","publisher":{"@id":"https:\/\/pabau.com\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pabau.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/pabau.com\/de\/#organization","name":"Pabau","url":"https:\/\/pabau.com\/de\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/pabau.com\/de\/#\/schema\/logo\/image\/","url":"https:\/\/pabau.com\/wp-content\/uploads\/2022\/05\/Logo-4-e1654525062364.png","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2022\/05\/Logo-4-e1654525062364.png","width":736,"height":195,"caption":"Pabau"},"image":{"@id":"https:\/\/pabau.com\/de\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Pabau\/","https:\/\/x.com\/pabaucrm","https:\/\/www.linkedin.com\/company\/pabau-ltd\/","https:\/\/www.instagram.com\/pabausoftware\/"],"description":"Pabau is an all-in-one healthcare practice management software platform designed for clinics, medspas, therapists, and medical professionals. It combines scheduling, electronic health records, clinical forms, payments, marketing automation, reporting, and patient engagement tools into one secure cloud system to help practices streamline operations and grow their business.","foundingDate":"2011-10-20","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"201","maxValue":"500"}},{"@type":"Person","@id":"https:\/\/pabau.com\/de\/#\/schema\/person\/5de22f4ff3ec59b1925ef02dce956d7d","name":"Katy Piper","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/03\/cropped-Snip20260306_177-96x96.png","url":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/03\/cropped-Snip20260306_177-96x96.png","contentUrl":"https:\/\/pabau.com\/wp-content\/uploads\/2026\/03\/cropped-Snip20260306_177-96x96.png","caption":"Katy Piper"},"description":"Katy Piper is a content writer covering aesthetics, dermatology, and clinic operations, with a knack for making clinical detail feel approachable. Outside of work, she's usually chasing her border collie around muddy fields or hunting down the best flat white in town.","url":"https:\/\/pabau.com\/de\/blog\/author\/katy-piper\/"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#faq-question-1","position":1,"url":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#faq-question-1","name":"What is ICD-10 Code C13.0?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"ICD-10 Code C13.0 is the billable ICD-10-CM diagnosis code for malignant neoplasm of postcricoid region, a subsite of the hypopharynx located posterior to the cricoid cartilage. It is valid for FY2026 HIPAA-covered transaction submission and falls within the C00-C14 block of the ICD-10-CM neoplasm chapter.","inLanguage":"de"},"inLanguage":"de"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#faq-question-2","position":2,"url":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#faq-question-2","name":"Is C13.0 a billable ICD-10-CM code?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"Yes. C13.0 is a fully billable, four-character ICD-10-CM diagnosis code valid for submission on HIPAA-covered transactions for fiscal year 2026 (October 1, 2025 through September 30, 2026). It is confirmed as billable across CMS, CDC\/NCHS, and AAPC authoritative sources.","inLanguage":"de"},"inLanguage":"de"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#faq-question-3","position":3,"url":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#faq-question-3","name":"What is the difference between C13.0 and C13.9?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"C13.0 specifies malignancy in the postcricoid region of the hypopharynx, while C13.9 indicates an unspecified hypopharynx malignancy. Use C13.0 when the pathology report or operative note explicitly identifies the postcricoid subsite. Use C13.9 only when clinical documentation does not specify the anatomical location within the hypopharynx.","inLanguage":"de"},"inLanguage":"de"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#faq-question-4","position":4,"url":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#faq-question-4","name":"What DRG is associated with C13.0?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"C13.0 groups under the MS-DRG v43.0 system when it is the principal diagnosis on an inpatient claim. The specific DRG depends on secondary diagnoses, the presence of CCs or MCCs, and procedures performed. Verify the exact DRG assignment against the current CMS IPPS Final Rule tables annually, as grouping logic changes each fiscal year.","inLanguage":"de"},"inLanguage":"de"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#faq-question-5","position":5,"url":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#faq-question-5","name":"What is the ICD-10 code for throat cancer?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"There is no single ICD-10-CM code for \"throat cancer\" because the throat encompasses multiple anatomical structures, each with its own code. Common options include C13.0-C13.9 for hypopharynx, C10.x for oropharynx, C14.0 for pharynx unspecified, and C32.x for larynx. The correct code depends on the specific anatomical subsite documented by the treating clinician or confirmed by pathology.","inLanguage":"de"},"inLanguage":"de"},{"@type":"Question","@id":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#faq-question-6","position":6,"url":"https:\/\/pabau.com\/de\/diagnostic-codes\/icd-10-code-c130\/#faq-question-6","name":"Which ICD-10 codes are related to hypopharynx cancer?","answerCount":1,"acceptedAnswer":{"@type":"Answer","text":"The C13 category covers all hypopharynx malignancies: C13.0 (postcricoid region), C13.1 (aryepiglottic fold, hypopharyngeal aspect), C13.2 (posterior wall), C13.8 (overlapping sites), and C13.9 (unspecified). Adjacent codes include C10.x for oropharynx, C14.0 for pharynx unspecified, C15.3 for cervical esophagus, and C32.1 for the laryngeal aspect of the aryepiglottic fold.","inLanguage":"de"},"inLanguage":"de"}]}},"yoast":{"focus_keyword":"ICD-10 Code C13.0","seo_title":"ICD-10 Code C13.0: Malignant neoplasm of postcricoid region","meta_description":"ICD-10 Code C13.0 covers malignant neoplasm of postcricoid region (hypopharynx). Billable for FY2026, with DRG grouping and coding guidance.","content_score":"60","is_cornerstone":"","related_keyphrases":[{"keyword":"hypopharynx cancer icd 10","score":61},{"keyword":"head and neck cancer icd 10 code","score":56},{"keyword":"C13 icd 10 code","score":93},{"keyword":"squamous cell carcinoma hypopharynx icd 10","score":56},{"keyword":"drg for hypopharynx cancer","score":61}]},"_links":{"self":[{"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/posts\/154642","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/users\/77"}],"replies":[{"embeddable":true,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/comments?post=154642"}],"version-history":[{"count":5,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/posts\/154642\/revisions"}],"predecessor-version":[{"id":182814,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/posts\/154642\/revisions\/182814"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/media\/154641"}],"wp:attachment":[{"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/media?parent=154642"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/categories?post=154642"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pabau.com\/de\/wp-json\/wp\/v2\/tags?post=154642"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}